Afamelanotide · source year
4 selected, source-linked Afamelanotide records carrying a 2018 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
4 selected records.
2 represented types.
4 distinct public records.
Cited chronology
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 25607635 at 2026-07-30T21:09:14.737Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2015-01-22. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 25607828 at 2026-07-30T21:09:14.737Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2015-01-22. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 26132941 at 2026-07-30T21:09:16.183Z. PubMed recorded a metadata revision date of 2018-11-13 and an Entrez history date of 2015-07-02. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03634137 at 2026-07-30T21:10:03.005Z. Its registry update date was 2018-08-16, and PeptideScanner's reviewed identity mapping was afamelanotide.
Source: ClinicalTrials.gov ↗